Go Pro
NASDAQ:INBS

Intelligent Bio Solutions Q2 2026 Earnings Report

Intelligent Bio Solutions logo
$1.77 -0.03 (-1.67%)
Closing price 09/23/2026 04:00 PM Eastern
Extended Trading
$1.82 +0.05 (+3.11%)
As of 07:41 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Intelligent Bio Solutions EPS Results

Actual EPS
-$2.82
Consensus EPS
$0.40
Beat/Miss
Missed by -$3.22
One Year Ago EPS
N/A

Intelligent Bio Solutions Revenue Results

Actual Revenue
$0.90 million
Expected Revenue
$5.50 million
Beat/Miss
Missed by -$4.60 million
YoY Revenue Growth
N/A

Intelligent Bio Solutions Announcement Details

Quarter
Q2 2026
Time
Before Market Opens
Conference Call Date
Thursday, February 12, 2026
Conference Call Time
7:00AM ET

Upcoming Earnings

Intelligent Bio Solutions' Q1 2027 earnings is estimated for Wednesday, November 11, 2026, based on past reporting schedules, with a conference call scheduled on Monday, November 9, 2026 at 9:30 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Intelligent Bio Solutions Earnings Headlines

While SpaceX Gets the Spotlight, FJET Is Building What Comes Next!
Starfighters Space (NYSE: FJET) operates the world's only commercial fleet of flight-ready Mach 2+ F-104 Starfighter aircraft, giving it a rare platform for high-speed flight testing, captive-carry missions and aerospace research. Its Wind Tunnel in the Sky concept exposes hardware to real high-speed atmospheric conditions, while new collaborations with Vaya Defense & Space and The Bionetics Corporation expand its reach into propulsion, hypersonic test articles and payload processing. FJET is also developing STARLAUNCH, an air-launched system targeting suborbital missions, positioning the company across testing, defense and launch.tc pixel
See More Intelligent Bio Solutions Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Intelligent Bio Solutions? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Intelligent Bio Solutions and other key companies, straight to your email.

About Intelligent Bio Solutions

Intelligent Bio Solutions (NASDAQ:INBS) is a life sciences company focused on non-invasive diagnostic and drug-screening technologies. Its primary product is the Intelligent Fingerprinting Drug Screening System, which analyzes sweat collected from a fingerprint to identify drug metabolites.

The system is designed to provide rapid, portable testing without blood or urine collection. It is intended for use by organizations such as employers, law enforcement agencies, drug-treatment providers, and other institutions that require convenient drug screening and monitoring.

The company’s technology originated with Intelligent Fingerprinting, a United Kingdom-based developer that was acquired by Intelligent Bio Solutions. Intelligent Bio Solutions, formerly known as GBS Inc., has pursued commercialization of the fingerprint-based testing platform in markets including the United States, the United Kingdom, Australia, and other international regions.

View Intelligent Bio Solutions Profile